Efficacy of povidone-iodine nasal rinse and mouth wash in COVID-19 management: a prospective, randomized pilot clinical trial (povidone-iodine in COVID-19 management)

Table 1 The participants’ demographic data

		PVP (n = 5)	NS (n = 6)	Control (n = 8)	Total (n = 19)
Sex	Male	3	4	5	12
	Female	2	2	3	7
Age	> 40 years	0	1	0	1
	30–39 years	4	1	5	10
	< 30 years	1	4	3	8
Received vaccination	1 dose	0	0	1	1
	2 doses	3	6	7	16
	3 doses	2	0	0	2
Time since last vaccination	< 3 months	1	2	4	7
	3–6 months	4	3	2	9
	> 6 months	0	1	2	3
Body mass index	18–25 kg/m²	1	1	2	4
	25–30 kg/m²	2	4	5	11
	30–35 kg/m²	0	0	1	1
	> 35 kg/m²	2	0	0	2

ISSN: 1471-2334